Description

Assay Development Service   

In response to customer inquiries, MBS announces the expansion of contract services offered to include ELISA development.  The assay development service will provide customers with refined, R&D use assays at the end of hybridoma development.   Optimization of reagents for assay applications has long been an area of core competency for MBS, used heavily in the development of internal products and services. It is with great excitement that we will, for the first time, be extending the benefit of that experience to our hybridoma development customers. 

Included in the service will be the development of an optimized ELISA using your predicted matrices, transfer of protocols, and training support; making our lab an extension of yours.